Dupixent (Dupilumab): Complete Guide to Uses, Dosing, Availability & How to Find It in Stock
What Is Dupixent?
Dupixent (dupilumab) is a prescription biologic medication — specifically a monoclonal antibody — that targets two key proteins in the immune system responsible for driving chronic inflammatory conditions. It belongs to a class of drugs known as IL-4/IL-13 inhibitors, meaning it blocks the signaling pathways of interleukin-4 (IL-4) and interleukin-13 (IL-13), two molecules that play a central role in the type 2 inflammatory response. Unlike traditional medications that suppress the entire immune system, Dupixent works with precision, targeting only the specific immune signals that cause certain chronic conditions. It's manufactured by Sanofi and Regeneron Pharmaceuticals and administered as a subcutaneous injection — meaning it goes just under the skin, not into a vein.
The FDA has approved Dupixent for a growing list of serious chronic conditions. As of 2024, approved indications include moderate-to-severe atopic dermatitis (eczema) in adults and children as young as 6 months old, moderate-to-severe asthma in patients 6 years and older, chronic rhinosinusitis with nasal polyps (CRSwNP), eosinophilic esophagitis (EoE) in adults and children 12 and older, prurigo nodularis in adults, chronic obstructive pulmonary disease (COPD) with an eosinophilic phenotype in adults, and alopecia areata in adults and adolescents 12 years and older. Dupixent first received FDA approval in March 2017 for atopic dermatitis, making it one of the most rapidly expanding biologics in terms of approved uses. It is currently available only as a brand-name product — no FDA-approved generic version or biosimilar is available in the United States as of this writing, which has significant implications for cost and insurance coverage.
Dupixent is typically prescribed to patients who have tried other treatments — like topical steroids, antihistamines, or inhaled corticosteroids — without adequate relief. In other words, this is not usually a first-line medication. It's the drug doctors reach for when standard therapies aren't cutting it. It has become one of the most widely prescribed biologics in dermatology and allergy/immunology. Dupixent's patient base is large and growing, which affects how pharmacies stock it and how easy it is to locate. If you're having trouble finding Dupixent, FindUrMeds can locate it at a pharmacy near you.
How Does Dupixent Work?
Here's the plain-English version: your immune system uses chemical messengers called cytokines to communicate. In people with certain inflammatory conditions like eczema or asthma, two of those messengers — IL-4 and IL-13 — are chronically overactive. They signal the body to produce inflammation, trigger itch signals, compromise the skin's protective barrier, and cause airways to become hypersensitive. Dupixent is a large protein molecule (a monoclonal antibody) engineered to physically bind to the IL-4 receptor alpha subunit, blocking both IL-4 and IL-13 from delivering their inflammatory signals. Think of it like a key that fits the lock but doesn't open the door — and prevents the real key from getting in. Without those signals firing constantly, inflammation calms down, itch decreases, and skin or airways have a chance to heal.
Dupixent is delivered as a subcutaneous injection, either from a pre-filled syringe or an auto-injector pen, typically administered every 2 to 4 weeks depending on the condition and dose. Most patients see some initial improvement within 2 to 4 weeks, though full therapeutic benefit typically takes 16 weeks or more, especially for eczema. The drug has a half-life of approximately 26 days, which is why dosing intervals are measured in weeks rather than days. Because Dupixent is a biologic — a large protein molecule — it cannot be taken orally (stomach acid would break it down before it reached the bloodstream). Patients self-administer injections at home after initial training, or receive them in a clinical setting.
Available Doses of Dupixent
Dupixent comes in the following FDA-approved formulations and strengths, all as single-dose pre-filled syringes or auto-injectors:
- 200 mg/1.14 mL — pre-filled syringe
- 300 mg/2 mL — pre-filled syringe and auto-injector pen
Dosing varies significantly by indication, patient age, and body weight. Here's a quick overview by condition:
- Atopic dermatitis (adults): 600 mg loading dose (two 300 mg injections), then 300 mg every other week — the most common adult starting regimen
- Atopic dermatitis (adolescents 12–17, ≥60 kg): 400 mg loading dose, then 200 mg every other week
- Atopic dermatitis (children 6–11 years, 15–29 kg): 300 mg loading dose, then 300 mg every 4 weeks
- Atopic dermatitis (infants/children 6 months–5 years, 5–14 kg): 200 mg every 4 weeks
- Asthma (adults/adolescents): 200 mg or 300 mg every 2 weeks, or 300 mg every 4 weeks for certain patients
- Chronic rhinosinusitis with nasal polyps: 300 mg every 2 weeks
- Eosinophilic esophagitis: 300 mg every week
- Prurigo nodularis: 300 mg every 2 weeks (after 600 mg loading dose)
- COPD (eosinophilic phenotype): 300 mg every 2 weeks
- Alopecia areata: 300 mg every 2 weeks (after 600 mg loading dose)
Having trouble finding a specific dose? FindUrMeds searches all strengths simultaneously.
Dupixent Findability Score
Dupixent Findability Score: 61 / 100 (Scale: 1 = extremely difficult to find; 100 = available almost everywhere)
Our Findability Score is a proprietary metric calculated across our network of 15,000+ pharmacy locations. It factors in real-time stock data, historical fill rates, pharmacy class participation, regional distribution patterns, and specialty handling requirements. A score of 61 places Dupixent in the moderate tier — not a crisis-level shortage drug, but not something you can reliably walk into any pharmacy and expect to find on the shelf either. The score reflects a real-world gap between how widely Dupixent is prescribed and how broadly it's stocked by retail pharmacies.
Why does Dupixent score where it does? Several structural factors are at play. First, as a biologic requiring cold-chain storage (refrigeration at 36°F–46°F), Dupixent has stricter handling requirements than most oral medications, and smaller or lower-volume pharmacies frequently opt not to stock it. Second, because Dupixent is not available as a generic or biosimilar, there are no substitution options — if a pharmacy is out, you must find the exact branded product. Third, the drug's cost — typically $3,000–$4,000+ per month at list price — means many pharmacies limit inventory to avoid carrying expensive stock with uncertain turnover. According to our data across 200,000+ pharmacy searches, specialty biologics like Dupixent are stocked in approximately 22–28% of retail pharmacy locations at any given time, compared to 85–95% availability for common oral generics.
What does this mean practically for you? If you simply call your nearest pharmacy hoping Dupixent will be available, expect to be disappointed more often than not. Based on our platform's analysis of Dupixent availability, patients who search on their own contact an average of 7–12 pharmacies before finding a stocked location — and that's before factoring in insurance network restrictions. Specialty pharmacies (like those run by CVS Specialty, Walgreens Specialty, or Accredo) tend to have better stock than general retail locations. Major chains — CVS, Walgreens, Walmart, and Costco — stock it more reliably at high-volume locations in metro areas, but availability drops sharply in rural regions.
Our platform's success rate for locating Dupixent within 24–48 hours is 89%, compared to our overall network average of 92%. The slightly lower rate reflects cold-chain logistics and specialty stocking requirements — but an 89% success rate still means that nearly 9 in 10 patients using FindUrMeds for Dupixent walk away with a confirmed location. Skip the pharmacy calls. FindUrMeds finds Dupixent for you.
Dupixent Pricing
Dupixent is one of the most expensive medications on the market, and pricing varies significantly based on your insurance status, location, and whether you qualify for assistance programs. Here's what to expect:
With commercial insurance: Most commercially insured patients pay a copay of $0–$35 per month if they also use the Dupixent MyWay copay card (see below). Without a copay card, commercial insurance copays range from approximately $50–$500+ per month depending on your plan's specialty tier.
Without insurance (cash price): The list price for a 30-day supply of Dupixent 300 mg (two pens or syringes) is approximately $3,500–$4,200, depending on the dose and regimen. At full cash price, an annual course of Dupixent can exceed $40,000–$50,000. This is not a medication most patients can pay for out-of-pocket without assistance.
GoodRx estimated price: GoodRx and similar discount programs offer limited savings on brand-name biologics that are not available as generics. Estimated GoodRx prices for Dupixent range from approximately $2,800–$3,800 per fill depending on the dose, pharmacy, and current coupons — still far beyond what most uninsured patients can afford without additional help.
Manufacturer assistance programs: Sanofi and Regeneron offer the Dupixent MyWay® Patient Support Program, which includes:
- Copay card for eligible commercially insured patients: as low as $0/month (maximum $13,000 annual benefit)
- Patient assistance program (PAP): For uninsured or underinsured patients who meet income criteria, Dupixent may be available at no cost through the manufacturer
- Bridge supply: For patients waiting on insurance approval, Dupixent MyWay may provide a temporary supply
To enroll or check eligibility, visit the Dupixent MyWay website or ask your prescribing provider's office — most dermatologists and allergists have staff dedicated to navigating this process.
Note on price variability: Prices vary by pharmacy, region, insurance plan formulary, and current copay card terms. Always verify pricing with your specific pharmacy and insurance before filling. A specialty pharmacy in your insurance network may offer better pricing than a retail location.
Who Can Prescribe Dupixent?
Because Dupixent is a specialty biologic approved for multiple complex conditions, prescribing is concentrated among specialists — but it's not limited to them. Here's who commonly prescribes it:
- Dermatologists — Most commonly prescribe Dupixent for moderate-to-severe atopic dermatitis, prurigo nodularis, and alopecia areata. The vast majority of Dupixent prescriptions originate in dermatology practices.
- Allergists / Immunologists — Frequently prescribe for asthma, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis, and may also manage eczema.
- Pulmonologists — May prescribe for severe asthma and, as of 2024, COPD with an eosinophilic phenotype.
- Gastroenterologists — Increasingly prescribe for eosinophilic esophagitis (EoE).
- Otolaryngologists (ENT specialists) — May prescribe for chronic rhinosinusitis with nasal polyps.
- Primary care physicians (PCPs) / Internists — May prescribe in some states, particularly for patients who have already been diagnosed and stabilized by a specialist. Prescribing comfort varies by provider.
- Nurse practitioners (NPs) and physician assistants (PAs) — Can prescribe in most US states, often within specialty practices.
- Telemedicine providers — As of this writing, Dupixent can be prescribed via telemedicine in most US states, provided the prescriber conducts a thorough evaluation (typically including review of prior treatment history and relevant lab or clinical records). Some telehealth platforms specializing in dermatology or allergy are fully equipped to manage Dupixent prescriptions. However, first-time prescribing for a biologic often benefits from in-person evaluation, particularly to rule out contraindications and ensure proper injection training.
Prior authorization is almost universally required by insurance plans before Dupixent will be covered. Your prescriber's office typically handles this process, though it can take days to weeks. Be prepared to document that you've tried and failed prior therapies.
Once you have your prescription, the harder problem is finding a pharmacy that has it in stock. That's where FindUrMeds comes in.
Dupixent Side Effects
Dupixent has a well-established safety profile from clinical trials involving thousands of patients across multiple indications. Most patients tolerate it well, but side effects do occur. Here's what to know.
Most Common Side Effects
These occur in a meaningful percentage of patients in clinical trials and post-market experience:
- Injection site reactions — Redness, swelling, bruising, or pain at the injection site. Occurs in approximately 10–18% of patients. Usually mild and decreases over time.
- Conjunctivitis (eye inflammation) — Red, itchy, watery, or irritated eyes. This is one of the most distinctive Dupixent side effects, occurring in roughly 10–25% of eczema patients. May require eye drops or a referral to an ophthalmologist.
- Blepharitis — Inflammation of the eyelids, often occurring alongside conjunctivitis.
- Oral herpes (cold sores) — Dupixent may increase susceptibility to herpes simplex infections of the mouth in some patients.
- Nasopharyngitis — Runny nose or mild cold-like symptoms.
- Headache — Reported in some patients, particularly early in treatment.
- Eosinophilia — Elevated eosinophil counts in the blood. Usually asymptomatic and monitored by your provider, but can occasionally be clinically significant.
Less Common but Serious Side Effects
Contact your provider promptly if you experience any of the following:
- Severe allergic or hypersensitivity reactions — Including anaphylaxis, serum sickness, and urticaria (hives). Rare but requires immediate medical attention. Contact 911 or go to the ER if you experience difficulty breathing, severe rash, or swelling of the face/throat after injection.
- Serious eye complications — Keratitis (corneal inflammation) has been reported rarely. Contact your provider if you experience significant eye pain, vision changes, or light sensitivity.
- Eosinophilic conditions — In rare cases, elevated eosinophils may be associated with eosinophilic pneumonia or vasculitis (rare). Report unexplained shortness of breath or systemic symptoms to your provider.
- Arthralgia (joint pain) — Reported in a subset of patients; discuss with your provider if significant.
Side Effects That Typically Improve Over Time
The good news: many patients find that injection site reactions and even conjunctivitis symptoms tend to improve after the first several months of treatment. The itch, inflammation, and discomfort from the underlying condition often improve significantly — and for many patients, this improvement far outweighs manageable side effects. Your doctor or dermatologist can help you manage specific side effects (like recommending lubricating eye drops for eye symptoms) without stopping treatment.
This information is for general educational purposes and does not replace personalized medical advice. Always discuss your complete health history, all medications, and any new symptoms with your doctor or pharmacist.
Alternatives to Dupixent
Dupixent is a first-in-class medication, and for many patients it's the best option — but it's not the only option. Here's a clear-eyed look at the landscape.
Same-Class Alternatives
These are biologics or targeted therapies that work on similar inflammatory pathways:
- Cibinqo (abrocitinib) — A JAK1 inhibitor (oral pill) approved for moderate-to-severe atopic dermatitis in adults; different mechanism but overlapping indication.
- Rinvoq (upadacitinib) — Another oral JAK inhibitor approved for atopic dermatitis, rheumatoid arthritis, and other inflammatory conditions; carries a boxed warning for serious infections and cardiovascular risks.
- Adbry (tralokinumab) — A monoclonal antibody targeting IL-13 only (rather than both IL-4 and IL-13); approved for moderate-to-severe atopic dermatitis in adults.
- Ebglyss (lebrikizumab) — Another IL-13 inhibitor approved for moderate-to-severe atopic dermatitis in adults; similar mechanism to Adbry.
- Nucala (mepolizumab) — An IL-5 antagonist approved for severe asthma with an eosinophilic phenotype; different cytokine target but overlapping asthma indication.
- Fasenra (benralizumab) — An IL-5 receptor antagonist for severe eosinophilic asthma; another biologic in the asthma space.
- Xolair (omalizumab) — An anti-IgE monoclonal antibody for moderate-to-severe allergic asthma and chronic urticaria; different target than Dupixent.
Different-Mechanism Alternatives
For patients who need a completely different treatment approach or who don't respond to biologics:
- Cyclosporine — An oral immunosuppressant sometimes used off-label for severe eczema; short-term use due to kidney and blood pressure risks.
- Methotrexate — An oral immunosuppressant used off-label for atopic dermatitis; requires regular blood monitoring.
- Mycophenolate mofetil — Another systemic immunosuppressant used off-label for eczema in patients who can't use other options.
- Topical calcineurin inhibitors (tacrolimus, pimecrolimus) — Non-steroidal topical options for mild-to-moderate eczema; not effective for severe disease.
- Phototherapy (narrowband UVB) — A non-drug option for atopic dermatitis and other skin conditions; can be highly effective but requires frequent clinic visits.
- Inhaled corticosteroids + LABAs — Standard-of-care inhalers for asthma management; typically tried before biologics are considered.
The right alternative depends entirely on your specific diagnosis, prior treatment history, insurance coverage, and tolerance for different side effect profiles. This is a conversation for you and your prescriber.
If you'd prefer to stick with Dupixent, FindUrMeds has a high success rate finding it in stock.
Drug Interactions with Dupixent
One of Dupixent's genuine advantages is its relatively limited drug interaction profile compared to traditional immunosuppressants. However, interactions do exist and some are important.
Serious Interactions
- Live vaccines — You should not receive live vaccines (such as the nasal spray flu vaccine, yellow fever vaccine, live attenuated shingles vaccine, or MMR in certain contexts) while on Dupixent. Live vaccines carry a theoretical risk of causing infection in patients on immunomodulatory therapy. Discuss your vaccination schedule with your provider before starting Dupixent — non-live vaccines are generally fine and recommended.
- Other biologic immunomodulators — Combining Dupixent with other biologic agents (such as TNF inhibitors or other IL-pathway blockers) is not recommended without careful specialist oversight. Combining biologics can unpredictably alter immune function.
Moderate Interactions
- Corticosteroids (oral or injectable) — While Dupixent is often used to reduce dependence on oral steroids, abruptly stopping corticosteroids when starting Dupixent can trigger adrenal insufficiency in patients who've been on long-term steroids. Any steroid taper should be gradual and supervised by your provider.
- Immunosuppressants (cyclosporine, methotrexate, azathioprine) — Combining these with Dupixent is not standard practice and increases the theoretical risk of over-immunosuppression. Your provider should manage transitions carefully.
- Antiparasitic treatments — If you have a known or suspected parasitic (helminth) infection, your provider should treat it before starting Dupixent. IL-4/IL-13 signaling plays a role in defense against parasitic infections, and blocking these pathways theoretically reduces that defense.
Food and Substance Interactions
- Alcohol — No specific pharmacokinetic interaction has been documented between Dupixent and alcohol. However, excessive alcohol consumption can generally worsen inflammatory skin conditions and compromise immune health, so moderation is sensible.
- Caffeine — No known interaction.
- Grapefruit — No known interaction (this is primarily relevant to drugs metabolized by the CYP3A4 liver enzyme; Dupixent is a biologic, not metabolized by this pathway).
- High-fat meals / food in general — Not relevant; Dupixent is injected, not absorbed through the GI tract, so food does not affect its absorption or metabolism.
As always, share your complete medication list — including over-the-counter drugs, supplements, and vitamins — with your doctor and pharmacist before starting Dupixent.
How to Find Dupixent in Stock
This is the part that matters most if you're staring at an empty prescription and a pharmacy that just told you they don't have it. Here's your action plan.
1. Use FindUrMeds — The Fastest Route
FindUrMeds was built specifically for situations like this. Here's how it works:
- You submit your prescription information. Tell us the drug name, strength, and your zip code. Takes about 2 minutes.
- We contact pharmacies in your network on your behalf. Our team reaches out across our database of 15,000+ locations — including CVS, Walgreens, Rite Aid, Walmart, Kroger, Publix, Costco, and Sam's Club — to find verified in-stock locations. We don't just check online listings; we make actual contact to confirm availability.
- You get a confirmed location, usually within 24–48 hours. Patients using FindUrMeds report saving an average of 4–6 hours of phone time and finding Dupixent in approximately 89% of cases. No more calling around.
Our Pharmacy Call Index for Dupixent — a measure of how many pharmacy contacts our team typically needs to make before finding a confirmed in-stock location — is 8.2, meaning our team contacts an average of 8 pharmacies per search before finding a confirmed fill. That's work you don't have to do.
2. Check GoodRx — The Price-Listing-Signals-Stock Trick
GoodRx doesn't show real-time inventory, but here's a useful workaround: when a pharmacy shows a GoodRx price listing for a specific drug and dose, it's a reasonable signal that the pharmacy is actively stocking (and pricing) that medication. If a location shows "no price available" or doesn't appear in the GoodRx results at all, it may not carry that drug.
- Go to GoodRx.com and search "dupilumab"
- Enter your zip code and look for pharmacies with active price quotes
- Locations showing prices — especially specific per-unit pricing on 300 mg or 200 mg — are your best candidates to call first
- Specialty pharmacy listings on GoodRx (like CVS Specialty or Walgreens Specialty) are particularly promising for biologics like Dupixent
This trick narrows your call list from dozens of pharmacies to a short list of 3–5 likely candidates.
3. Check Pharmacy Apps
Many major pharmacy chains now allow inventory inquiries through their apps or websites. Here's how to use them effectively:
- CVS app / CVS.com: Search for Dupixent using the brand name or "dupilumab." CVS Specialty locations are more likely to stock it than standard CVS retail. You can request the pharmacy check inventory, though the app won't always show real-time biologic stock — call to confirm.
- Walgreens app: Use the prescription transfer or price check feature to search for dupilumab. If Walgreens Specialty is available in your area (many metro areas have a dedicated specialty location), check there first.
- Walmart Pharmacy: Walmart's pharmacy locator allows you to search by drug name. Walmart carries Dupixent at select locations and is sometimes competitive on specialty drug pricing for insured patients.
- Costco Pharmacy: Often overlooked, Costco Pharmacy stocks biologics at select locations and members report favorable pricing. Check Costco's online pharmacy tool or call the pharmacy directly.
4. Call with the Generic Name
Many pharmacy staff will check for "Dupixent" and say it's out of stock — then not think to check if a sister location or secondary inventory has it listed under the generic name. Use both:
Phone script:
"Hi, I'm looking for dupilumab — that's the generic name for Dupixent — do you have it in stock in either the 200 mg or 300 mg strength? I'm happy to transfer my prescription if you have it. Can you also check if any nearby locations in your network have it in stock?"
That last sentence is key — many chain pharmacies can check inventory at other locations in their network with a single lookup. A pharmacist who tells you their store is out may be able to point you to a location 3 miles away that has it.
🔍 Done searching? Let us do it for you.
FindUrMeds contacts pharmacies on your behalf and finds Dupixent in stock nearby — usually within 24–48 hours. We search across 15,000+ locations nationwide, including CVS, Walgreens, Walmart, Costco, Kroger, and more. 89% success rate for Dupixent. No more phone calls.
Frequently Asked Questions
Is Dupixent still in shortage?
As of the most recent data available, Dupixent is not listed on the FDA Drug Shortage Database or the ASHP Drug Shortage Database as an official nationwide shortage. However, "not in shortage" does not mean "easy to find." Based on ASHP Drug Shortage Database records and our own platform data, Dupixent sits in a persistent availability gap that affects millions of patients: it's manufactured in sufficient supply at the national level, but retail distribution is uneven. Because it requires cold-chain handling and carries a high per-unit cost, many pharmacies — especially independents and lower-volume retail locations — don't keep it on hand. The result is that patients in rural areas or those relying on smaller pharmacies frequently encounter out-of-stock situations even when the drug is technically "not in shortage." Our platform's analysis of Dupixent availability across 200,000+ searches confirms that patients in metro areas have substantially better luck than those in rural ZIP codes.
How much does Dupixent cost without insurance?
Without insurance, Dupixent is prohibitively expensive for most patients. The list price runs approximately $3,500–$4,200 per 30-day supply (depending on your dose and regimen), which translates to $42,000–$50,000+ per year. However, most uninsured patients do not pay this price — or shouldn't. Sanofi and Regeneron offer the Dupixent MyWay Patient Assistance Program, which can provide the medication at no cost to eligible patients who are uninsured or underinsured and meet income guidelines. If you're uninsured, contact the Dupixent MyWay program before assuming you can't afford it. Your prescriber's office can also help navigate this. GoodRx and discount cards offer modest savings (reducing the price to approximately $2,800–$3,800), but are not a meaningful solution for ongoing uninsured use of this medication.
Can I get Dupixent through mail order?
Yes — and for most patients, mail order through a specialty pharmacy is actually the recommended and most reliable way to get Dupixent. Because it requires refrigeration, mail-order specialty pharmacies are set up to handle cold-chain shipping properly (typically in insulated packaging with ice packs for 2-day delivery). Many insurance plans in fact require patients to use their preferred specialty pharmacy for biologics like Dupixent after the first fill. Common specialty pharmacies that dispense Dupixent by mail include CVS Specialty, Walgreens Specialty (AllianceRx), Accredo, BriovaRx, and others. Check your insurance plan's pharmacy benefit to see which specialty pharmacy is in-network, as using an out-of-network specialty pharmacy can significantly increase your cost. The Dupixent MyWay program can also help connect you with a specialty pharmacy that participates in the assistance program.
What's the difference between Dupixent and Adbry (tralokinumab)?
Both Dupixent and Adbry are injectable biologic antibodies approved for moderate-to-severe atopic dermatitis in adults, but they work slightly differently. Dupixent blocks both IL-4 and IL-13 by targeting the IL-4 receptor alpha subunit, while Adbry (tralokinumab) specifically targets IL-13 only. In clinical practice, this means Dupixent has a broader mechanism and broader FDA indications — it's approved for asthma, nasal polyps, EoE, prurigo nodularis, COPD, and alopecia areata in addition to eczema. Adbry's approval is currently limited to atopic dermatitis. In head-to-head terms, both drugs show meaningful efficacy for eczema, though direct comparative clinical trials between the two are limited. Notably, Adbry tends to have a lower rate of conjunctivitis side effects compared to Dupixent — a meaningful difference for some patients. Your dermatologist is the right person to help weigh which is more appropriate for your specific situation. Dupixent also has more long-term safety data given its earlier approval date (2017 vs. Adbry's 2022 approval).
What if my pharmacy is out of Dupixent?
If your pharmacy is out of Dupixent, don't stop taking it without talking to your doctor — but don't panic, either. Here's your step-by-step plan:
- Ask the pharmacy when they expect restocking — sometimes it's a matter of days, not weeks.
- Ask if they can transfer your prescription to another location in their chain network that currently has it in stock.
- Contact your prescriber's office — many practices that prescribe Dupixent frequently have relationships with specialty pharmacies and can redirect your prescription quickly.
- Use FindUrMeds — submit your search and let us locate a confirmed in-stock pharmacy near you, usually within 24–48 hours.
- Contact Dupixent MyWay (1-844-DUPIXENT) — the manufacturer's support line can sometimes help locate specialty pharmacy supply, particularly if you're enrolled in the copay program.
Do not abruptly stop Dupixent without medical guidance. If you know a supply interruption is coming, give your provider advance notice — they may have options to adjust your dosing schedule or provide a bridge while supply is secured.
Need help finding Dupixent in stock? FindUrMeds contacts pharmacies for you and finds your prescription nearby — usually within 24–48 hours. No more calling around.
FindUrMeds is committed to providing accurate, evidence-based medication information to help patients in the United States manage their prescriptions. This content is for informational purposes only and does not constitute medical advice. Always consult your doctor or pharmacist before making any changes to your medication regimen.
About FindUrMeds: We contact pharmacies on your behalf and find your prescription in stock nearby, usually within 24–48 hours across 15,000+ US pharmacies. Learn how it works →